ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 246 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $528,856 | -7.3% | 32,545 | +5.4% | 0.02% | -11.8% |
| Q1 2024 | $570,693 | -37.2% | 30,865 | +6.3% | 0.02% | -45.2% |
| Q4 2023 | $909,211 | +47.3% | 29,039 | -1.9% | 0.03% | +34.8% |
| Q3 2023 | $617,072 | -5.2% | 29,610 | +9.0% | 0.02% | -4.2% |
| Q2 2023 | $650,673 | +7.2% | 27,168 | -15.8% | 0.02% | 0.0% |
| Q1 2023 | $607,076 | +147607.1% | 32,257 | +24.8% | 0.02% | +41.2% |
| Q4 2022 | $411 | -99.9% | 25,846 | -1.8% | 0.02% | -15.0% |
| Q3 2022 | $431,000 | +16.2% | 26,324 | +0.1% | 0.02% | +25.0% |
| Q2 2022 | $371,000 | -26.5% | 26,309 | +26.2% | 0.02% | -11.1% |
| Q1 2022 | $505,000 | +1.4% | 20,845 | -2.3% | 0.02% | +12.5% |
| Q4 2021 | $498,000 | +27.4% | 21,332 | -9.3% | 0.02% | +14.3% |
| Q3 2021 | $391,000 | -6.0% | 23,528 | +38.1% | 0.01% | -6.7% |
| Q2 2021 | $416,000 | +61.2% | 17,043 | +109.5% | 0.02% | -34.8% |
| Q4 2014 | $258,000 | -45.9% | 8,136 | -61.5% | 0.02% | -42.5% |
| Q2 2014 | $477,000 | -49.7% | 21,131 | -44.3% | 0.04% | -58.8% |
| Q4 2013 | $948,000 | -17.6% | 37,920 | -9.5% | 0.10% | -20.5% |
| Q3 2013 | $1,151,000 | +14.0% | 41,895 | -24.7% | 0.12% | +1.7% |
| Q2 2013 | $1,010,000 | – | 55,645 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |